Outpatient Inhaled Corticosteroid Use in Bronchopulmonary
Dysplasia
Cynara Leon, MD, MPH1, Amanda Martin,
BA1, Lisa R. Young, MD1, Brianna C.
Aoyama, MD, MHS2, Jessica L. Rice, MD,
MHS1, Jelte Kelchtermans, MD1,
Joseph M. Collaco, MD, PhD 2, Sharon A.
McGrath-Morrow, MD, MBA1*
1Division of Pulmonary and Sleep Medicine, Children’s
Hospital of Philadelphia and University of Pennsylvania, Philadelphia,
PA
2Eudowood Division of Pediatric Respiratory Sciences,
Johns Hopkins University, Baltimore, MD
*Corresponding Author: Sharon A. McGrath‐Morrow, MD, MBA,
Division of Pulmonary and Sleep Medicine, Children’s Hospital of
Philadelphia, Perelman School of Medicine at the University of
Pennsylvania, Philadelphia, PA, USA. Email:
mcgrathmos@chop.edu
Funding/Support : This work was supported by a R03HD109442 (JMC,
SAM), T32-HL160493-01 (CL, JK), RFA-ES-18-003 (SAM), Parker B Francis
Foundation (JK) and K24HL143281 (LRY).
The funding sources had no involvement in the writing of the manuscript
or the decision to submit.
Keywords: inhaled corticosteroids, bronchopulmonary dysplasia,
outpatient, symptoms, acute care use
Running Head: Inhaled corticosteroids and BPD